Reply: Potential role of Janus kinase inhibitors in COVID-19

被引：18

作者：

Napolitano, Maddalena ^{[1
]}

Fabbrocini, Gabriella ^{[2
]}

Patruno, Cataldo ^{[3
]}

机构：

[1] Univ Molise, Dept Hlth Sci Vincenzo Tiberio, Campobasso, Italy

[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 01期

关键词：

BARICITINIB;

D O I：

10.1016/j.jaad.2020.04.098

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E65 / E65

页数：1

共 6 条

[1] Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial [J].

Guttman-Yassky, Emma ;

Thaci, Diamant ;

Pangan, Aileen L. ;

Hong, H. Chih-ho ;

Papp, Kim A. ;

Reich, Kristian ;

Beck, Lisa A. ;

Mohamed, Mohamed-Eslam F. ;

Othman, Ahmed A. ;

Anderson, Jaclyn K. ;

Gu, Yihua ;

Teixeira, Henrique D. ;

Silverberg, Jonathan I. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) :877-884

[2] Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence [J].

Napolitano, Maddalena ;

Fabbrocini, Gabriella ;

Cinelli, Eleonora ;

Stingeni, Luca ;

Patruno, Cataldo .

JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 :89-93

[3] In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) [J].

Parmentier J.M. ;

Voss J. ;

Graff C. ;

Schwartz A. ;

Argiriadi M. ;

Friedman M. ;

Camp H.S. ;

Padley R.J. ;

George J.S. ;

Hyland D. ;

Rosebraugh M. ;

Wishart N. ;

Olson L. ;

Long A.J. .

BMC Rheumatology, 2 (1)

[4] The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [J].

Peterson, Danielle ;

Damsky, William ;

King, Brett .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) :E223-E226

[5] Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment [J].

Pu, Szu-Yuan ;

Xiao, Fei ;

Schor, Stanford ;

Bekerman, Elena ;

Zanini, Fabio ;

Barouch-Bentov, Rina ;

Nagamine, Claude M. ;

Einav, Shirit .

ANTIVIRAL RESEARCH, 2018, 155 :67-75

[6] Baricitinib as potential treatment for 2019-nCoV acute respiratory disease [J].

Richardson, Peter ;

Griffin, Ivan ;

Tucker, Catherine ;

Smith, Dan ;

Oechsle, Olly ;

Phelan, Anne ;

Stebbing, Justin .

LANCET, 2020, 395 (10223) :E30-E31

← 1 →